Financial Architects (New Jersey)’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-30
| Closed | – | – | 1090 |
|
|
2019
Q1 | $0 | Hold |
30
| – | – | ﹤0.01% | 1293 |
|
|
2018
Q4 | $0 | Hold |
30
| – | – | ﹤0.01% | 1209 |
|
|
2018
Q3 | $0 | Hold |
30
| – | – | ﹤0.01% | 1276 |
|
|
2018
Q2 | $0 | Hold |
30
| – | – | ﹤0.01% | 1320 |
|
|
2018
Q1 | $0 | Hold |
30
| – | – | ﹤0.01% | 1253 |
|
|
2017
Q4 | $0 | Hold |
30
| – | – | ﹤0.01% | 1347 |
|
|
2017
Q3 | $0 | Hold |
30
| – | – | ﹤0.01% | 1382 |
|
|
2017
Q2 | $0 | Hold |
30
| – | – | ﹤0.01% | 1401 |
|
|
2017
Q1 | $0 | Hold |
30
| – | – | ﹤0.01% | 1457 |
|
|
2016
Q4 | $0 | Hold |
30
| – | – | ﹤0.01% | 1360 |
|
|
2016
Q3 | $0 | Hold |
30
| – | – | ﹤0.01% | 1393 |
|
|
2016
Q2 | $0 | Buy |
+30
| New | – | ﹤0.01% | 1381 |
|